| scholarly article | Q13442814 |
| P50 | author | Eric D. Peterson | Q63021326 |
| Mark B Effron | Q63645100 | ||
| Tracy Y Wang | Q86192699 | ||
| Larry R Jackson | Q88870205 | ||
| Douglas E Faries | Q90413135 | ||
| Brian Baker | Q92207412 | ||
| Marjorie E Zettler | Q114430921 | ||
| John C Messenger | Q115679666 | ||
| P2093 | author name string | David J Cohen | |
| Lisa A McCoy | |||
| Christine Ju | |||
| P2860 | cites work | ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and | Q82711468 |
| Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation | Q28188284 | ||
| Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin | Q28200091 | ||
| An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators | Q28254763 | ||
| The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR): building a national clinical data repository | Q30654790 | ||
| Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study | Q34009506 | ||
| Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities | Q34549376 | ||
| Clopidogrel with or without omeprazole in coronary artery disease | Q34660303 | ||
| Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome | Q34956075 | ||
| Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials | Q37590925 | ||
| Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole | Q41128197 | ||
| Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myoc | Q46868498 | ||
| Prasugrel versus clopidogrel in patients with acute coronary syndromes | Q46915044 | ||
| Contemporary use of platelet function and pharmacogenomic testing among patients with acute myocardial infarction undergoing percutaneous coronary intervention in the United States | Q48074441 | ||
| Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition | Q50244980 | ||
| Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel. | Q50357085 | ||
| Treatment with Adenosine Diphosphate Receptor Inhibitors—Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) study design: Expanding the paradigm of longitudinal observational research | Q56928525 | ||
| P433 | issue | 10 | |
| P921 | main subject | clopidogrel | Q410237 |
| P577 | publication date | 2016-10-21 | |
| P1433 | published in | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | Q19880670 |
| P1476 | title | Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events Aft | |
| P478 | volume | 5 |
| Q50516738 | The natural history of perforated foregut ulcers after repair by omental patching or primary closure. | cites work | P2860 |
Search more.